ABCG2 and brain neoplasm: These findings are consistent with what was described in previous studies, where the decrease in the expression and function of ABCG2 occurred after treatment with 1 mM melatonin in brain tumor stem cells and colon cancer by inducing the methylation of its promoter [50,51].